Newsletter | September 22, 2021

09.22.21 -- A Gene Therapy Manufacturing Giant

Exclusive Articles
VCs Breath New Life Into Life Sciences Industrials

The “industrials” or supplier sector of the biopharma industry, in a significant change from the past, is now receiving an extra financial boost from VC funding. Why should their biopharma customers care?

Creating A Culture of Innovation In Any Size Organization

A company’s size and culture play a large role in how it defines and executes innovation.

Genesis Of A Gene Therapy Manufacturing Giant
Dr. Timothy Miller is trying to build one of the world’s largest adeno-associated virus (AAV) gene therapy manufacturing facilities. The cofounder and CEO of Columbus, OH-based Forge Biologics has been scratching the regenerative medicine leadership itch for quite a while now.
How A Larger Biopharma Is Preparing To Get Back To The Office

In this executive virtual roundtable segment, Britt Byers, SVP of HR for Kyowa Kirin North America, a global biopharma, discusses plans for returning to in-office operations in the U.S. and some of the methodology used to make the decision.

September 2021 Digital Edition

Inside you will find more on:

  • CEO Insights
  • Leadership Tips
  • Market Research
  • Clinical Trials

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.